Type I interferon–related kidney disorders
- 23 March 2022
- journal article
- review article
- Published by Elsevier in Kidney International
- Vol. 101 (6) , 1142-1159
Abstract
No abstract availableKeywords
Funding Information
- European Research Council
- Horizon 2020 Framework Programme (786142)
This publication has 150 references indexed in Scilit:
- Glucocorticoids target suppressor of cytokine signaling 1 (SOCS1) and type 1 interferons to regulate Toll-like receptor–induced STAT1 activationProceedings of the National Academy of Sciences, 2011
- Tartrate-resistant acid phosphatase deficiency causes a bone dysplasia with autoimmunity and a type I interferon expression signatureNature Genetics, 2011
- Recruited inflammatory monocytes stimulate antiviral Th1 immunity in infected tissueProceedings of the National Academy of Sciences, 2010
- The Type I Interferon Signaling Pathway Is a Target for Glucocorticoid InhibitionMolecular and Cellular Biology, 2010
- Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophagesProceedings of the National Academy of Sciences, 2010
- Viruses and Kidney Disease: Beyond HIVSeminars in Nephrology, 2008
- CD4 Binding Affinity Determines Human Immunodeficiency Virus Type 1-Induced Alpha Interferon Production in Plasmacytoid Dendritic CellsJournal of Virology, 2008
- Association of the IRF5 risk haplotype with high serum interferon‐α activity in systemic lupus erythematosus patientsArthritis & Rheumatism, 2008
- STAT4and the Risk of Rheumatoid Arthritis and Systemic Lupus ErythematosusNew England Journal of Medicine, 2007
- Mutations in the gene encoding the 3′-5′ DNA exonuclease TREX1 are associated with systemic lupus erythematosusNature Genetics, 2007